118 related articles for article (PubMed ID: 8200950)
1. Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover.
Tokita A; Kelly PJ; Nguyen TV; Qi JC; Morrison NA; Risteli L; Risteli J; Sambrook PN; Eisman JA
J Clin Endocrinol Metab; 1994 Jun; 78(6):1461-6. PubMed ID: 8200950
[TBL] [Abstract][Full Text] [Related]
2. Genetic influence on bone turnover in postmenopausal twins.
Garnero P; Arden NK; Griffiths G; Delmas PD; Spector TD
J Clin Endocrinol Metab; 1996 Jan; 81(1):140-6. PubMed ID: 8550741
[TBL] [Abstract][Full Text] [Related]
3. Genetic factors in bone turnover.
Kelly PJ; Hopper JL; Macaskill GT; Pocock NA; Sambrook PN; Eisman JA
J Clin Endocrinol Metab; 1991 Apr; 72(4):808-13. PubMed ID: 2005205
[TBL] [Abstract][Full Text] [Related]
4. Genetic and constitutional influences on bone turnover markers: a study of male twin pairs.
Donescu OS; Battié MC; Kaprio J; Levalahti E; Risteli J; Eyre D; Videman T
Calcif Tissue Int; 2007 Feb; 80(2):81-8. PubMed ID: 17308989
[TBL] [Abstract][Full Text] [Related]
5. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
Kobayashi Y; Ochi M; Tokue A
Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
Tähtelä R; Thölix E
Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558
[TBL] [Abstract][Full Text] [Related]
7. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
9. Perinatal collagen turnover markers in intrauterine growth restriction.
Gourgiotis D; Briana DD; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
[TBL] [Abstract][Full Text] [Related]
10. Type 1 collagen marker of bone turnover, insulin-like growth factor, and leptin in dichorionic twins with discordant birth weight.
Bajoria R; Sooranna SR; Chatterjee R
J Clin Endocrinol Metab; 2006 Nov; 91(11):4696-701. PubMed ID: 16940458
[TBL] [Abstract][Full Text] [Related]
11. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
Eriksen EF; Charles P; Melsen F; Mosekilde L; Risteli L; Risteli J
J Bone Miner Res; 1993 Feb; 8(2):127-32. PubMed ID: 8442431
[TBL] [Abstract][Full Text] [Related]
12. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.
Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Szymańska A; Nahaczewska W
Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245
[TBL] [Abstract][Full Text] [Related]
13. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
14. Heritability assessment of cartilage metabolism. A twin study on circulating procollagen IIA N-terminal propeptide (PIIANP).
Munk HL; Svendsen AJ; Hjelmborg Jv; Sorensen GL; Kyvik KO; Junker P
Osteoarthritis Cartilage; 2014 Aug; 22(8):1142-7. PubMed ID: 25008205
[TBL] [Abstract][Full Text] [Related]
15. Increased degradation of type I collagen in patients with inflammatory bowel disease.
Silvennoinen J; Risteli L; Karttunen T; Risteli J
Gut; 1996 Feb; 38(2):223-8. PubMed ID: 8801201
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of serum markers of type I collagen synthesis and degradation and serum osteocalcin in maternal and umbilical circulation.
Yasumizu T; Kato J
Endocr J; 1996 Apr; 43(2):191-5. PubMed ID: 8793335
[TBL] [Abstract][Full Text] [Related]
17. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.
Kushida K; Takahashi M; Kawana K; Inoue T
J Clin Endocrinol Metab; 1995 Aug; 80(8):2447-50. PubMed ID: 7629240
[TBL] [Abstract][Full Text] [Related]
18. Age-related changes in bone mineral density and serum bone-related proteins in premenopausal and postmenopausal Japanese women.
Yasumizu T; Okuno T; Fukada Y; Hoshi K
Endocr J; 2000 Apr; 47(2):103-9. PubMed ID: 10943733
[TBL] [Abstract][Full Text] [Related]
19. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum levels of type I collagen-related proteins after surgically induced menopause and correlations with bone loss in the lumbar spine.
Yasumizu T; Fukada Y; Hoshi K
Endocr J; 1999 Apr; 46(2):337-43. PubMed ID: 10460020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
